Does METRONIDAZOLE Cause Hyperleukocytosis? 7 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Hyperleukocytosis have been filed in association with METRONIDAZOLE (metronidazole). This represents 0.0% of all adverse event reports for METRONIDAZOLE.
7
Reports of Hyperleukocytosis with METRONIDAZOLE
0.0%
of all METRONIDAZOLE reports
5
Deaths
7
Hospitalizations
How Dangerous Is Hyperleukocytosis From METRONIDAZOLE?
Of the 7 reports, 5 (71.4%) resulted in death, 7 (100.0%) required hospitalization.
Is Hyperleukocytosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for METRONIDAZOLE. However, 7 reports have been filed with the FAERS database.
What Other Side Effects Does METRONIDAZOLE Cause?
Drug ineffective (3,336)
Nausea (1,944)
Off label use (1,507)
Headache (1,167)
Vomiting (1,160)
Abdominal pain (1,076)
Pyrexia (1,048)
Diarrhoea (1,041)
Drug hypersensitivity (994)
Dizziness (900)
What Other Drugs Cause Hyperleukocytosis?
CYCLOPHOSPHAMIDE (55)
PREDNISONE (54)
TRETINOIN (52)
ARSENIC TRIOXIDE (49)
RITUXIMAB (49)
ACETAMINOPHEN (44)
VINCRISTINE (44)
DEXAMETHASONE (42)
PANTOPRAZOLE (38)
AMOXICILLIN (36)
Which METRONIDAZOLE Alternatives Have Lower Hyperleukocytosis Risk?
METRONIDAZOLE vs METRONIDAZOLE\METRONIDAZOLE
METRONIDAZOLE vs METYRAPONE
METRONIDAZOLE vs MEXILETINE
METRONIDAZOLE vs MIANSERIN
METRONIDAZOLE vs MICAFUNGIN